{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T11:19:44Z","timestamp":1765711184372,"version":"3.48.0"},"reference-count":65,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"unspecified","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"GLRA German Leprosy and Tuberculosis Relief Association","award":["Project 7.18.20.06_RESEARCH_CHAGAS-MONTEAGUDO"],"award-info":[{"award-number":["Project 7.18.20.06_RESEARCH_CHAGAS-MONTEAGUDO"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,8,9]]},"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Veterinary ivermectin (vet-IVM) has been used widely in Latin America against COVID-19, despite the lack of scientific evidence and potential risks. Widespread vet-IVM intake was also discovered against Chagas disease during a study in Bolivia prior to the pandemic. All vet-IVM-related data were extracted to understand this phenomenon, its extent and underlying factors and to discuss potential implications for the current pandemic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A convergent mixed-methods study design including a survey, qualitative in-depth interviews (IDI) and focus group discussions (FGD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>A cross-sectional study conducted in 2018 covering the geographic area of Monteagudo, an endemic municipality for Chagas disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>A total of 669 adult household representatives from 26 communities participated in the survey, supplemented by 14 IDI and 2 FGD among patients, relatives and key informants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>9 IDI and 2 FGD contained narratives on vet-IVM use against Chagas disease. Five main themes emerged: (1) the extent of the vet-IVM phenomenon, (2) the perception of vet-IVM as a treatment for Chagas disease, (3) the vet-IVM market and the controversial role of stakeholders, (4) concerns about potential adverse events and (5) underlying factors of vet-IVM use against Chagas disease.<\/jats:p>\n                    <jats:p>In quantitative analysis, 28% of participants seropositive for Chagas disease had taken vet-IVM. Factors associated with multivariate analysis were advanced age (OR 17.01, 95\u2009CI 1.24 to 36.55, p=0.027 for age above 60\u2009years), the experience of someone close as information source (OR 3.13, 95\u2009CI 1.62 to 5.02, p&lt;0.001), seropositivity for Chagas disease (OR 3.89, 95\u2009CI 1.39 to 6.20, p=0.005) and citing the unavailability of benznidazole as perceived healthcare barrier (OR 2.3, 95\u2009CI 1.45 to 5.18, p=0.002). Participants with an academic education were less likely to report vet-IVM intake (OR 0.12, 95\u2009CI 0.01 to 0.78, p=0.029).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Social determinants of health, the unavailability of treatment and a wonder drug image might contribute to the phenomenon of vet-IVM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-058572","type":"journal-article","created":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T07:25:12Z","timestamp":1663399512000},"page":"e058572","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Understanding the widespread use of veterinary ivermectin for Chagas disease, underlying factors and implications for the COVID-19 pandemic: a convergent mixed-methods study"],"prefix":"10.1136","volume":"12","author":[{"given":"Boris","family":"Apodaca Michel","sequence":"first","affiliation":[{"name":"Department of Medical and Social Projects, DAHW, W\u00fcrzburg, Germany"},{"name":"Medical Department, Centro Integral Dermatol\u00f3gico, Monteagudo, Plurinational State of Bolivia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Navarro","sequence":"additional","affiliation":[{"name":"Department of Public Health, Science History and Gynecology, Universidad Miguel Hern\u00e1ndez, Alicante, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Pritsch","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Tropical Medicine, University Hospital LMU Munich, Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy Douglas","family":"Du Plessis","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Applied Mathematics, University of Cape Town, Rondebosch, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Shock","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Applied Mathematics, University of Cape Town, Rondebosch, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva-Maria","family":"Schwienhorst-Stich","sequence":"additional","affiliation":[{"name":"Department of General Practice, University Hospital W\u00fcrzburg, W\u00fcrzburg, Germany"},{"name":"Medical Faculty, University of W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janina","family":"Zirkel","sequence":"additional","affiliation":[{"name":"Medical Faculty, University of W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Schrader","sequence":"additional","affiliation":[{"name":"Department of General Practice, University Hospital W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Saavedra Irala","sequence":"additional","affiliation":[{"name":"Department of Medical and Social Projects, DAHW, W\u00fcrzburg, Germany"},{"name":"Medical Department, Centro Integral Dermatol\u00f3gico, Monteagudo, Plurinational State of Bolivia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"Rubilar","sequence":"additional","affiliation":[{"name":"Department of Medical and Social Projects, DAHW, W\u00fcrzburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolin","family":"Gunesch","sequence":"additional","affiliation":[{"name":"Department of Medical and Social Projects, DAHW, W\u00fcrzburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christa","family":"Kasang","sequence":"additional","affiliation":[{"name":"Department of Medical and Social Projects, DAHW, W\u00fcrzburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Zoller","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Respiratory Medicine, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7974-7603","authenticated-orcid":false,"given":"Ildiko","family":"Gagyor","sequence":"additional","affiliation":[{"name":"Department of General Practice, University Hospital W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2029-3659","authenticated-orcid":false,"given":"Sandra","family":"Parisi","sequence":"additional","affiliation":[{"name":"Department of Medical and Social Projects, DAHW, W\u00fcrzburg, Germany"},{"name":"Department of General Practice, University Hospital W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,9,17]]},"reference":[{"key":"2025121403184038000_12.9.e058572.1","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2017.11"},{"key":"2025121403184038000_12.9.e058572.2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41429-020-0336-z","article-title":"Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen","volume":"73","author":"Heidary","year":"2020","journal-title":"J Antibiot"},{"key":"2025121403184038000_12.9.e058572.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2011.02735.x"},{"key":"2025121403184038000_12.9.e058572.4","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antiviral Res"},{"key":"2025121403184038000_12.9.e058572.5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.3071"},{"key":"2025121403184038000_12.9.e058572.6","doi-asserted-by":"crossref","unstructured":"Roman YM , Burela PA , Pasupuleti V . Ivermectin for the treatment of COVID-19: a systematic review and meta-analysis of randomized controlled trials. Clin Infect Dis 2021:ciab591.doi:10.1093\/cid\/ciab591","DOI":"10.1101\/2021.05.21.21257595"},{"key":"2025121403184038000_12.9.e058572.7","unstructured":"Pharmacologic treatments for COVID-19 patients. Available: https:\/\/covid-nma.com\/living_data\/index.php?comparison=36 [Accessed 11 Aug 2021]."},{"key":"2025121403184038000_12.9.e058572.8","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110364","article-title":"Inhaled route and anti-inflammatory action of ivermectin: do they hold promise in fighting against COVID-19?","volume":"146","author":"Mittal","year":"2021","journal-title":"Med Hypotheses"},{"key":"2025121403184038000_12.9.e058572.9","doi-asserted-by":"crossref","unstructured":"Popp M , Stegemann M , Metzendorf M-I . Ivermectin for preventing and treating COVID-19. Cochrane Database Syst Rev 2021;2021.doi:10.1002\/14651858.CD015017.pub2","DOI":"10.1002\/14651858.CD015017.pub2"},{"key":"2025121403184038000_12.9.e058572.10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"P\u00e9rez-Molina","year":"2018","journal-title":"The Lancet"},{"key":"2025121403184038000_12.9.e058572.11","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/trstmh\/trz132","article-title":"Stigma, participation restriction and mental distress in patients affected by leprosy, cutaneous leishmaniasis and Chagas disease: a pilot study in two co-endemic regions of eastern Colombia","volume":"114","author":"G\u00f3mez","year":"2020","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2025121403184038000_12.9.e058572.12","doi-asserted-by":"crossref","DOI":"10.5334\/gh.891","article-title":"COVID-19: implications for people with Chagas disease","volume":"15","author":"Zaidel","year":"2020","journal-title":"Glob Heart"},{"key":"2025121403184038000_12.9.e058572.13","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taaa179","article-title":"Neglected tropical diseases in non-endemic countries in the era of COVID-19 pandemic: the great forgotten","volume":"28","author":"Tilli","year":"2021","journal-title":"J Travel Med"},{"key":"2025121403184038000_12.9.e058572.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507574"},{"key":"2025121403184038000_12.9.e058572.15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005251","article-title":"\"I Cannot Be Worried\": Living with Chagas Disease in Tropical Bolivia","volume":"11","author":"Forsyth","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2025121403184038000_12.9.e058572.16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/01459740.2017.1360878","article-title":"From lemongrass to ivermectin: Ethnomedical management of Chagas disease in tropical Bolivia","volume":"37","author":"Forsyth","year":"2018","journal-title":"Med Anthropol"},{"key":"2025121403184038000_12.9.e058572.17","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02762005000800002"},{"key":"2025121403184038000_12.9.e058572.18","unstructured":"Ivermectin and COVID-19: how a flawed database shaped the pandemic response of several Latin-American countries. Available: https:\/\/www.isglobal.org\/en\/healthisglobal\/-\/custom-blog-portlet\/ivermectin-and-COVID-19-how-a-flawed-database-shaped-the-COVID-19-response-of-several-latin-american-countries\/2877257\/0 [Accessed 11 Aug 2021]."},{"key":"2025121403184038000_12.9.e058572.19","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.20-0271"},{"key":"2025121403184038000_12.9.e058572.20","unstructured":"Un Grupo evang\u00e9lico peruano inyecta un medicamento veterinario a miles de personas para La covid-19. Available: https:\/\/elpais.com\/sociedad\/2020-06-19\/un-grupo-evangelico-peruano-inyecta-un-medicamento-veterinario-a-miles-de-personas.html [Accessed 11 Aug 2021]."},{"key":"2025121403184038000_12.9.e058572.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104805"},{"key":"2025121403184038000_12.9.e058572.22","doi-asserted-by":"crossref","DOI":"10.1007\/s12038-020-00067-w","article-title":"Drug targets for COVID-19 therapeutics: ongoing global efforts","volume":"45","author":"Saxena","year":"2020","journal-title":"J Biosci"},{"key":"2025121403184038000_12.9.e058572.23","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.psep.2021.06.040","article-title":"A critical review on environmental presence of pharmaceutical drugs tested for the covid-19 treatment","volume":"152","author":"Nippes","year":"2021","journal-title":"Process Saf Environ Prot"},{"key":"2025121403184038000_12.9.e058572.24","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.130808","article-title":"COVID-19 and ivermectin: potential threats associated with human use","volume":"1243","author":"Zaheer","year":"2021","journal-title":"J Mol Struct"},{"key":"2025121403184038000_12.9.e058572.25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008752","article-title":"\"We have already heard that the treatment doesn't do anything, so why should we take it?\": A mixed method perspective on Chagas disease knowledge, attitudes, prevention, and treatment behaviour in the Bolivian Chaco","volume":"14","author":"Parisi","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"2025121403184038000_12.9.e058572.26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.gheart.2015.07.004","article-title":"Electrocardiographic and echocardiographic abnormalities in Chagas disease: findings in residents of rural Bolivian communities hyperendemic for Chagas disease","volume":"10","author":"Fernandez","year":"2015","journal-title":"Glob Heart"},{"key":"2025121403184038000_12.9.e058572.27","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.12117"},{"key":"2025121403184038000_12.9.e058572.28","doi-asserted-by":"publisher","DOI":"10.1136\/ebnurs-2019-103145"},{"key":"2025121403184038000_12.9.e058572.29","doi-asserted-by":"crossref","unstructured":"Kuckartz U . Qualitative Text Analysis: A Guide to Methods, Practice & Using Software. 1 Oliver\u2019s Yard, 55 City Road, London EC1Y 1SP United Kingdom: SAGE Publications Ltd, 2014.","DOI":"10.4135\/9781446288719"},{"key":"2025121403184038000_12.9.e058572.30","unstructured":"Understanding robust standard errors. Available: https:\/\/data.library.virginia.edu\/understanding-robust-standard-errors\/ [Accessed 07 Jun 2022]."},{"key":"2025121403184038000_12.9.e058572.31","doi-asserted-by":"crossref","DOI":"10.1186\/1746-4269-8-26","article-title":"Can Andean medicine coexist with biomedical healthcare? A comparison of two rural communities in Peru and Bolivia","volume":"8","author":"Mathez-Stiefel","year":"2012","journal-title":"J Ethnobiol Ethnomed"},{"key":"2025121403184038000_12.9.e058572.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2014.07.005"},{"key":"2025121403184038000_12.9.e058572.33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2183\/pjab.87.13","article-title":"\u2018Wonder drug\u2019 from Japan: the human use perspective","volume":"87","author":"Crump","year":"2011","journal-title":"Proc Jpn Acad Ser B"},{"key":"2025121403184038000_12.9.e058572.34","doi-asserted-by":"crossref","DOI":"10.4103\/ijdvl.IJDVL_840_18","article-title":"Wonder drug for worms: a review of three decades of ivermectin use in dermatology","volume":"85","author":"Gowtham","year":"2019","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2025121403184038000_12.9.e058572.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2005.08.014"},{"key":"2025121403184038000_12.9.e058572.36","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/jac\/dkz524","article-title":"Safety of high-dose ivermectin: a systematic review and meta-analysis","volume":"75","author":"Navarro","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2025121403184038000_12.9.e058572.37","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/02701960.2013.844693","article-title":"A qualitative analysis of how elders seek and disseminate health information","volume":"35","author":"Altizer","year":"2014","journal-title":"Gerontol Geriatr Educ"},{"key":"2025121403184038000_12.9.e058572.38","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s40615-020-00833-4","article-title":"Racial, economic, and health inequality and COVID-19 infection in the United States","volume":"8","author":"Abedi","year":"2021","journal-title":"J Racial Ethn Health Disparities"},{"key":"2025121403184038000_12.9.e058572.39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.12688\/wellcomeopenres.15922.2","article-title":"Black, Asian and minority ethnic groups in England are at increased risk of death from COVID-19: indirect standardisation of NHS mortality data","volume":"5","author":"Aldridge","year":"2020","journal-title":"Wellcome Open Res"},{"key":"2025121403184038000_12.9.e058572.40","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268820002915","article-title":"COVID-19 mortality in an area of northeast Brazil: epidemiological characteristics and prospective spatiotemporal modelling","volume":"148","author":"Andrade","year":"2020","journal-title":"Epidemiol Infect"},{"key":"2025121403184038000_12.9.e058572.41","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/ije\/dyaa193","article-title":"Does level of education influence mortality of SARS-CoV-2 in a developing country?","volume":"49","author":"Concepci\u00f3n-Zavaleta","year":"2021","journal-title":"Int J Epidemiol"},{"key":"2025121403184038000_12.9.e058572.42","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0140-6736(20)31104-1","article-title":"Voluntary collective isolation as a best response to COVID-19 for Indigenous populations? A case study and protocol from the Bolivian Amazon","volume":"395","author":"Kaplan","year":"2020","journal-title":"The Lancet"},{"key":"2025121403184038000_12.9.e058572.43","doi-asserted-by":"crossref","DOI":"10.1186\/s12939-020-01178-4","article-title":"The challenges facing Indigenous communities in Latin America as they confront the COVID-19 pandemic","volume":"19","author":"Meneses-Navarro","year":"2020","journal-title":"Int J Equity Health"},{"key":"2025121403184038000_12.9.e058572.44","unstructured":"Weltgesundheitsorganisation editor . Integrating neglected tropical diseases into global health and development. Geneva: World Health Organization, 2017."},{"key":"2025121403184038000_12.9.e058572.45","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.4269\/ajtmh.20-1185","article-title":"Case report: COVID-19 and Chagas disease in two coinfected patients","volume":"103","author":"Alberca","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"2025121403184038000_12.9.e058572.46","first-page":"33","article-title":"Chagas disease in Latin America: an epidemiological update based on 2010 estimates","volume":"90","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"2025121403184038000_12.9.e058572.47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106037","article-title":"Ivermectin: repurposing a multipurpose drug for Venezuela's humanitarian crisis","volume":"56","author":"Perez-Garcia","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"2025121403184038000_12.9.e058572.48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242184"},{"key":"2025121403184038000_12.9.e058572.49","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-66063-0","article-title":"Biomagnification and body distribution of ivermectin in dung beetles","volume":"10","author":"Verd\u00fa","year":"2020","journal-title":"Sci Rep"},{"key":"2025121403184038000_12.9.e058572.50","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.scitotenv.2017.10.331","article-title":"Ivermectin residues disrupt dung beetle diversity, soil properties and ecosystem functioning: an interdisciplinary field study","volume":"618","author":"Verd\u00fa","year":"2018","journal-title":"Sci Total Environ"},{"key":"2025121403184038000_12.9.e058572.51","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/d41586-020-02958-2","article-title":"Latin America's embrace of an unproven COVID treatment is hindering drug trials","volume":"586","author":"Mega","year":"2020","journal-title":"Nature"},{"key":"2025121403184038000_12.9.e058572.52","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJMc1917344","article-title":"Serious Ivermectin Toxicity and Human ABCB1 Nonsense Mutations","volume":"383","author":"Baudou","year":"2020","journal-title":"N Engl J Med"},{"key":"2025121403184038000_12.9.e058572.53","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.20-0812"},{"key":"2025121403184038000_12.9.e058572.54","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdisas.2020.100119","article-title":"Effects of misinformation on COVID-19 individual responses and recommendations for resilience of disastrous consequences of misinformation","volume":"8","author":"Barua","year":"2020","journal-title":"Prog Disaster Sci"},{"key":"2025121403184038000_12.9.e058572.55","doi-asserted-by":"crossref","first-page":"i15","DOI":"10.1093\/inthealth\/ihw002","article-title":"Leaving no one behind: a neglected tropical disease indicator and tracers for the sustainable development goals","volume":"8 Suppl 1","author":"Fitzpatrick","year":"2016","journal-title":"Int Health"},{"key":"2025121403184038000_12.9.e058572.56","doi-asserted-by":"publisher","DOI":"10.1093\/inthealth\/ihu037"},{"key":"2025121403184038000_12.9.e058572.57","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0140-6736(16)00043-X","article-title":"Neglected tropical diseases in the sustainable development goals","volume":"387","author":"Engels","year":"2016","journal-title":"The Lancet"},{"key":"2025121403184038000_12.9.e058572.58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005759","article-title":"Global health policy and neglected tropical diseases: then, now, and in the years to come","volume":"11","author":"F\u00fcrst","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2025121403184038000_12.9.e058572.59","first-page":"11","article-title":"Addressing inequity: neglected tropical diseases and human rights","volume":"20","author":"Sun","year":"2018","journal-title":"Health Hum Rights"},{"key":"2025121403184038000_12.9.e058572.60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218138","article-title":"\"I can't read and don't understand\": Health literacy and health messaging about folic acid for neural tube defect prevention in a migrant population on the Myanmar-Thailand border","volume":"14","author":"Gilder","year":"2019","journal-title":"PLoS One"},{"key":"2025121403184038000_12.9.e058572.61","doi-asserted-by":"publisher","DOI":"10.1093\/her\/cyr012"},{"key":"2025121403184038000_12.9.e058572.62","doi-asserted-by":"crossref","first-page":"89","DOI":"10.47276\/lr.77.2.89","article-title":"Can social marketing approaches change community attitudes towards leprosy?","volume":"77","author":"Brown","year":"2006","journal-title":"Lepr Rev"},{"key":"2025121403184038000_12.9.e058572.63","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-020-01214-8","article-title":"Drug misuse in the veterinary setting: an under-recognized Avenue","volume":"23","author":"Anand","year":"2021","journal-title":"Curr Psychiatry Rep"},{"key":"2025121403184038000_12.9.e058572.64","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-0361.2002.tb00893.x"},{"key":"2025121403184038000_12.9.e058572.65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008954","article-title":"COVID-19 in the Americas and the erosion of human rights for the poor","volume":"14","author":"Hotez","year":"2020","journal-title":"PLoS Negl Trop Dis"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-058572","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T11:18:52Z","timestamp":1765711132000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-058572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":65,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9,17]]},"published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1136\/bmjopen-2021-058572"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-058572","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}